|
|
|
|
|
|
||
|
|
||||
|
|
||||
|
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Epidemiology and Cancer Control |
Division of Epidemiology and Biostatistics [T.S.S., B.J.M., V.K., P.J.J., F.G.D.], School of Public Health, University of Illinois at Chicago, IL 60612; and Department of Pathology [J.M.B.], M.D. Anderson Cancer Center, University of Texas, Houston, TX 77030-4095
2 Address correspondence and reprint requests to Tanya Surawicz, Division of Epidemiology and Biostatistics (M/C 922), School of Public Health, University of Illinois at Chicago, 2121 West Taylor Street, Chicago, IL 60612-7260.
Abstract
The Central Brain Tumor Registry of the United States (CBTRUS) obtained 5 years of incidence data (1990-1994)—including reports on all primary brain and CNS tumors—from 11 collaborating state cancer registries. Data were available for 20,765 tumors located in the brain, meninges, and other CNS sites, including the pituitary and pineal glands. The average annual incidence was estimated at 11.5 cases per 100,000 person-years. The higher incidence of tumors in male patients (12.1 per 100,000 person-years) than in female patients (11.0 per 100,000 person-years) was statistically significant (P<0.05); the higher incidence in whites (11.6 per 100,000 person-years) compared with blacks (7.8 per 100,000 person-years) was statistically significant (P<0.05). The most frequently reported histologies were meningiomas (24.0%) and glioblastomas (22.6%). Higher rates for glioblastomas, anaplastic astrocytomas, oligodendrogliomas, anaplastic oligodendrogliomas, ependymomas, mixed gliomas, astrocytomas not otherwise specified, medulloblastomas, lymphomas, and germ cell tumors in male than in female patients were statistically significant (P<0.05), with relative risks (RR) ranging from 1.3 to 3.4. Meningiomas were the only tumors with a significant excess in females (RR=0.5). We noted higher occurrence rates in whites than in blacks for the following histologies: diffuse astrocytomas, anaplastic astrocytomas, glioblastomas, oligodendrogliomas, ependymomas, mixed gliomas, astrocytomas NOS, medulloblastomas, nerve sheath tumors, hemangioblastomas, and germ cell tumors, with RRs ranging from 1.5 to 3.4. Racial differences in occurrence rates were not observed for predominately benign meningiomas or pituitary tumors. This study represents the largest compilation of data on primary brain and CNS tumors in the United States. Standard reporting definitions and practices must be universally adopted to improve the quality and use of cancer registry data.
References
Annegers, J.F., and Paleologos, N. (1994) Intracranial neoplasia. In: Gorelick, P.B., and Alter, M., (Eds.), Handbook of Neuroepidemiology. New York: Marcel Dekker, pp.295 -313.
Bunin, G., Surawicz, T.S., Witman, P.A., Preston-Martin, S., Davis, F., and Bruner, J.M. (1997) The descriptive epidemiology of craniopharyngioma. Neurosurg. Focus 3, 1-5.
Chang, Y., and Horoupian, D.S. (1994) Pathology of benign brain tumors. In: Morantz, R.A., and Walsh, J.W. (Eds.), Brain Tumors: An Encyclopedic Text. New York: Marcel Dekker, pp. 19-44.
Chen, V.W. (1995) Should we or shouldn't we compare incidence rates among registries? In: Howe, H.L. (Ed.), Cancer Incidence in North America, 1988-1991. Sacramento: North American Association of Central Cancer Registries, pp.V1 -V6.
Chen, V.W., Wu, X.C., and Andrews, P.A. (Eds.) (1998) Cancer in North America, 1990-1994, Vol.1 . Sacramento: North American Association of Central Cancer Registries.
Cote, T.R., Manns, A., Hardy, C.R., Yellin, F.J., Hartge, P., and
the AIDS/Cancer Study Group (1996) Epidemiology of brain lymphoma
among people with or without acquired immunodeficiency syndrome. J.
Natl. Cancer Inst. 88,675
-679.
Davis, F.G., and Preston-Martin, S. (1998) Epidemiology: Incidence and survival. In: Bigner, D.D., McLendon, R.E., and Bruner, J.M. (Eds.), Russell and Rubinstein's Pathology of the Nervous System, Vol. 1. London: Arnold, pp. 5-45.
Davis, F.G., Malinski, N., Haenszel, W., Chang, J., Flannery, J., Gershman, S., Dibble, R., and Bigner, D.D. (1996) Primary brain tumor incidence rates in four United States regions, 1985-1989: A pilot study. Neuroepidemiology 15,103 -12.[CrossRef][Web of Science][Medline]
Davis, F.G., Bruner, J.M., and Surawicz, T.S. (1997) The rationale for standardized registration and reporting of brain and central nervous system tumors in population-based cancer registries. Neuroepidemiology 16,308 -316.[CrossRef][Web of Science][Medline]
EDITS [computer program]. (1997) Version 2.00. Atlanta, Ga: Centers for Disease Control and Prevention.
Esteve, J., Benhamou, E., and Raymond, L. (1994) Statistical Methods in Cancer Research, Vol.IV . Lyon, France: International Agency for Research on Cancer, World Health Organization.
Heshmat, M.Y., Kovi, J., Simpson, C., Kennedy, J., and Fan, K.J. (1976) Neoplasms of the central nervous system. Incidence and population selectivity in the Washington DC, metropolitan area. Cancer 38,2135 -2142.[CrossRef][Web of Science][Medline]
Huston, S.L., Dickinson, C., Herman, D., Conlisk, E., and Lengerich, E.J. (1998) Completeness of female breast cancer case ascertainment by the North Carolina Central Cancer Registry. J. Registry Manage. 25,56 -59.
Kleihues, P., Burger, P.C., and Scheithauer, B.W. (1993) The new WHO classification of brain tumours. Brain Pathol. 3,255 -268.[Web of Science][Medline]
Kuratsu, J., and Ushio, Y. (1996) Epidemiological study of primary intracranial tumors: A regional survey in Kumamoto Prefecture in the southern part of Japan. J. Neurosurg. 84,946 -950.[Web of Science][Medline]
Kurland, L.T., Schoenberg, B.S., Annegers, J.F., Okazaki, H., and Molgaad, C.A. (1982) The incidence of primary intracranial neoplasms in Rochester, Minnesota 1935-1977. Ann. N. Y. Acad. Sci. 381,6 -16.[CrossRef][Web of Science][Medline]
Longstreth, W.T., Jr., Dennis, L.K., McGuire, U.M., Drangsholt, M.T., and Koepsell, T.D. (1993) Epidemiology of intracranial meningioma. Cancer 72,639 -648.[CrossRef][Web of Science][Medline]
Louis, D.N., and Gusella, J.F. (1995) A tiger behind many doors: Multiple genetic pathways to malignant glioma. Trends Genet. 11,412 -415.[CrossRef][Web of Science][Medline]
Mahaley, M.S., Jr., Mettlin, C., Natarajan, N., Laws, E.R., Jr., and Peace, B.B. (1989) National survey of patterns of care of brain-tumor patients. J. Neurosurg. 71,826 -836.[Web of Science][Medline]
National Cancer Institute [CD-ROM] (1997)Surveillance, Epidemiology, and End Results (1973-1994) . Bethesda, Md: U.S. Department of Health and Human Services.
Parkin, D.M., Shanmugaratnam, K., Sobin, L., Ferlay, J., and Whelan, S.I. (1998) Histological groups for comparative studies. International Agency for Research on Cancer (IARC) Technical Report No. 31, World Health Organization. Lyon: France.
Percy, C., Van Holten, V., and Muir, C.M. (Eds.) (1990) International Classification of Diseases for Oncology. Second edition. Geneva, Switzerland: World Health Organization.
Preston-Martin, S. (1989) Descriptive epidemiology of primary tumors of the brain, cranial nerves, and cranial meninges in Los Angeles County. Neuroepidemiology 8, 283-295.[CrossRef][Web of Science][Medline]
Radhakrishnan, K., Mokri, B., Parisi, J.E., O'Fallon, W.M., Sunku, J., and Kurland, L.T. (1995) The trends in incidence of primary brain tumors in the population of Rochester, Minnesota. Ann. Neurol. 37,67 -73.[CrossRef][Web of Science][Medline]
Robinson, N., Beral, V., and Ashley, J.S. (1979) Incidence of pituitary adenoma in women. Lancet 2, 630. (Letter)
SAS [computer program] (1988), Version 6. Cary, NC: SAS Institute.
Schoenberg, B.S., Christine, B.W., and Whisnant, J.P.
(1976) The descriptive epidemiology of primary intracranial
neoplasms: The Connecticut experience. Am. J.
Epidemiol. 104,499
-510.
Ries, L.A.G., Kosary, C.L., Hankey, B.F., Miller, B.A., and Edwards, B.K. (Eds.) (1998) SEER Cancer statistics review 1973-1995 (preliminary edition). SEER Web site. Last updated June 19, 1998; cited November 11, 1997. World Wide Web URL: <http://www-seer.ims.nci.nih.gov/>.
Velema, J.P., and Percy, C.L. (1987) Age curves of central nervous system tumor incidence in adults: Variation of shape by histologic type. J. Natl. Cancer Inst. 79,623 -629.
Walker, A.E., Robins, M., and Weinfeld, F.D. (1985)
Epidemiology of brain tumors: The national survey of intracranial neoplasms.
Neurology 35,219
-226.
World Health Organization (1976) ICD-O: International Classification of Diseases for Oncology, 1st edition. Geneva, Switzerland: World Health Organization.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  S. H. Golden, K. A. Robinson, I. Saldanha, B. Anton, and P. W. Ladenson Prevalence and Incidence of Endocrine and Metabolic Disorders in the United States: A Comprehensive Review J. Clin. Endocrinol. Metab., June 1, 2009; 94(6): 1853 - 1878. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Smith, D. Zurakowski, A. Saad, R. M. Scott, and M. A. Moses Urinary Biomarkers Predict Brain Tumor Presence and Response to Therapy Clin. Cancer Res., April 15, 2008; 14(8): 2378 - 2386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-H. Toh, M. Castillo, A.M.-C. Wong, K.-C. Wei, H.-F. Wong, S.-H. Ng, and Y.-L. Wan Primary Cerebral Lymphoma and Glioblastoma Multiforme: Differences in Diffusion Characteristics Evaluated with Diffusion Tensor Imaging AJNR Am. J. Neuroradiol., March 1, 2008; 29(3): 471 - 475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Inglese, S. Brown, G. Johnson, M. Law, E. Knopp, and O. Gonen Whole-Brain N-Acetylaspartate Spectroscopy and Diffusion Tensor Imaging in Patients with Newly Diagnosed Gliomas: A Preliminary Study AJNR Am. J. Neuroradiol., November 1, 2006; 27(10): 2137 - 2140. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Cha, L. Yang, G. Johnson, A. Lai, M.-H. Chen, T. Tihan, M. Wendland, and W.P. Dillon Comparison of Microvascular Permeability Measurements, Ktrans, Determined with Conventional Steady-State T1-Weighted and First-Pass T2*-Weighted MR Imaging Methods in Gliomas and Meningiomas. AJNR Am. J. Neuroradiol., February 1, 2006; 27(2): 409 - 417. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hoffman, J. M. Propp, and B. J. McCarthy Temporal trends in incidence of primary brain tumors in the United States, 1985-1999 Neuro-oncol, January 1, 2006; 8(1): 27 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Cohen, E. A. Knopp, H. Rusinek, J. S. Babb, D. Zagzag, and O. Gonen Assessing Global Invasion of Newly Diagnosed Glial Tumors with Whole-Brain Proton MR Spectroscopy AJNR Am. J. Neuroradiol., October 1, 2005; 26(9): 2170 - 2177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Cohen, E. A. Knopp, H. Rusinek, S. Liu, and O. Gonen Brain Compression without Global Neuronal Loss in Meningiomas: Whole-Brain Proton MR Spectroscopy Report of 2 Cases AJNR Am. J. Neuroradiol., October 1, 2005; 26(9): 2178 - 2182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Fang, M. Kulldorff, and D. I. Gregorio Brain cancer mortality in the United States, 1986 to 1995: A geographic analysis Neuro-oncol, July 1, 2004; 6(3): 179 - 187. [Abstract] [PDF]
|
|
|
|
|
|
S. L. Chua, M. A. Rosenthal, S. S. Wong, D. M. Ashley, A.-m. Woods, A. Dowling, and L. M. Cher Phase 2 study of temozolomide and Caelyx in patients with recurrent glioblastoma multiforme Neuro-oncol, January 1, 2004; 6(1): 38 - 43. [Abstract] [PDF]
|
|
|
|
 |
|
 I-M. Siu, A. Lal, J. R. Blankenship, N. Aldosari, and G. J. Riggins c-Myc Promoter Activation in Medulloblastoma Cancer Res., August 15, 2003; 63(16): 4773 - 4776. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wrensch, Y. Minn, T. Chew, M. Bondy, and M. S. Berger Epidemiology of primary brain tumors: Current concepts and review of the literature Neuro-oncol, October 1, 2002; 4(4): 278 - 299. [Abstract] [PDF]
|
|
|
|
 |
|
 U. Buhring, U. Herrlinger, T. Krings, R. Thiex, M. Weller, and W. Kuker MRI features of primary central nervous system lymphomas at presentation Neurology, August 14, 2001; 57(3): 393 - 396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Jukich, B. J. McCarthy, T. S. Surawicz, S. Freels, and F. G. Davis Trends in incidence of primary brain tumors in the United States, 1985-1994 Neuro-oncol, July 1, 2001; 3(3): 141 - 151. [Abstract] [PDF]
|
|
|
|
|
|
F. G. Davis, V. Kupelian, S. Freels, B. McCarthy, and T. Surawicz Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups Neuro-oncol, July 1, 2001; 3(3): 152 - 158. [Abstract] [PDF]
|
|
|
|
 |
|
 M. A. Rosenthal, B. Kavar, J. S. Hill, D. J. Morgan, R. L. Nation, S. S. Stylli, R. L. Basser, S. Uren, H. Geldard, M. D. Green, et al. Phase I and Pharmacokinetic Study of Photodynamic Therapy for High-Grade Gliomas Using a Novel Boronated Porphyrin J. Clin. Oncol., January 15, 2001; 19(2): 519 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Das, C A T Chapman, and W M Yap Histological subtypes of symptomatic central nervous system tumours in Singapore J. Neurol. Neurosurg. Psychiatry, March 1, 2000; 68(3): 372 - 374. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
